Bile acids are known

to be involved in hepatocyte cell survival pathways. In this regard, hydrophobic bile acids have been reported to be cytotoxic and to induce apoptosis in hepatocytes.35 In contrast, hydrophilic bile acids such as ursodeoxycholic acid (UDCA) and conjugates have been reported to prevent apoptosis possibly through activation of the AKT and ERK1/2 signaling pathways.36, 37 Conjugates of UDCA have been shown to activate the ERK1/2 and AKT signaling pathways in primary hepatocytes in culture.36, 37 The current data suggest that activation of these signaling pathways by TUDCA may be through the S1P2 in primary hepatocytes (Fig. 4). Other laboratories have reported that bile acids may increase the cellular c-AMP that prevents

apoptosis.38 BMS-354825 mw The movement of ABC transporters in hepatocytes from intracellular locations to the canalicular membrane as well as their activity may also be partially controlled by the activation of PI3 kinase through the S1P2.39-41 The data suggest that activation of S1P2 may have effects on survival pathways and movement of ABC transporters in primary hepatocytes. Our current study strongly suggests that the S1P2 is the major GPCR activated by TCA and other conjugated bile acids in hepatocytes. This conclusion is based on the following lines of experimentation: 1. Screening of individual GPCRs in the lipid-activated phylogenetic family showed that only S1P2 was significantly activated by TCA in HEK293 cells (Fig. 1). These Silmitasertib research buy cells lack a bile acid transporter; hence, TCA, a highly hydrophilic bile acid, must activate cell signaling pathways by binding to cell surface receptors. In addition, S1P2 mRNA is highly expressed in mouse, rat, and human hepatocytes (Supporting Fig. 2). In contrast, TGR5/M-BAR mRNA level is very low compared with S1P2 in primary hepatocytes. All these data point to S1P2 as another GPCR activated by bile acids. TCA rapidly activates the ERK1/2 and

AKT signaling pathways in primary rat hepatocytes and following intestinal infusion into a biliary diverted rat.14, 26 In addition, TCA is also an excellent activator of FXR in primary rat hepatocytes and in vivo models.26 Our current model suggests that both the medchemexpress ERK1/2 and the AKT pathways are activated by TCA through S1P2. These data indicate that S1P2 may play an important role in the regulation of hepatic glucose, bile acid, and lipid metabolism through coordinate activation of ERK1/2, AKT and FXR. In this regard, we have observed that S1P2−/− mice have fatty livers compared with wild-type control mice (unpublished data). In summary, TCA activated the S1P2 in rodent hepatocytes and in vivo causing activation of both the ERK1/2 and AKT pathways in primary hepatocytes. Activation of the AKT pathway appears to be essential for optimal activation of the nuclear receptor FXR by conjugated bile acids.